Emcure Pharms Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EMCURE PHARMS LTD, and what generic and branded alternatives to EMCURE PHARMS LTD drugs are available?
EMCURE PHARMS LTD has two approved drugs.
There are two tentative approvals on EMCURE PHARMS LTD drugs.
Summary for Emcure Pharms Ltd
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Emcure Pharms Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emcure Pharms Ltd | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 202063-002 | Sep 11, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Emcure Pharms Ltd | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 200771-002 | Feb 14, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Emcure Pharms Ltd | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 200771-001 | Feb 14, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Emcure Pharms Ltd | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 202063-001 | Sep 11, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
